Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis

<table>The clinical course and the changes of patient’s serum amyloid A (SAA) levels. The tocilizumab treatment controlled her SAA levels, although there were transient SAA level elevations due to a urinary tract infection.</table>

Case Reports in Nephrology

fig4

Figure 4

Figure 4: Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis 